APO Research
Talk to an analyst

APO RESEARCH · REPORT

Androgen Receptor (AR) Antagonist

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Androgen Receptor (AR) Antagonist Market Analysis and Forecast 2026-2032

27 December 2025196 pages

Choose your research edition.

Industry ResearchAndrogen Receptor (AR) Antagonist Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Androgen Receptor (AR) Antagonist Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Androgen Receptor (AR) Antagonist Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Androgen Receptor (AR) Antagonist Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Androgen Receptor (AR) Antagonist Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Androgen Receptor (AR) Antagonist market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Androgen Receptor (AR) Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Androgen Receptor (AR) Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Androgen Receptor (AR) Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Androgen Receptor (AR) Antagonist is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Androgen Receptor (AR) Antagonist include Kaituo Pharmaceutical, Pfizer, Hengrui Medicine, Bayer, R&D Systems, Janssen Pharmaceuticals and Astellas Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Androgen Receptor (AR) Antagonist, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Androgen Receptor (AR) Antagonist, also provides the sales of main regions and countries. Of the upcoming market potential for Androgen Receptor (AR) Antagonist, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Androgen Receptor (AR) Antagonist sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Androgen Receptor (AR) Antagonist market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Androgen Receptor (AR) Antagonist sales, projected growth trends, production technology, application and end-user industry.

Androgen Receptor (AR) Antagonist Segment by Company

Kaituo Pharmaceutical

Pfizer

Hengrui Medicine

Bayer

R&D Systems

Janssen Pharmaceuticals

Astellas Pharma

Androgen Receptor (AR) Antagonist Segment by Type

Steroidal AR Antagonists

Nonsteroidal AR Antagonists

Androgen Receptor (AR) Antagonist Segment by Application

Prostate Cancer

Breast Cancer

Others

Androgen Receptor (AR) Antagonist Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgen Receptor (AR) Antagonist market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Androgen Receptor (AR) Antagonist and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgen Receptor (AR) Antagonist.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Androgen Receptor (AR) Antagonist in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Androgen Receptor (AR) Antagonist manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgen Receptor (AR) Antagonist sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Steroidal AR Antagonists Major Manufacturers Table 3. Nonsteroidal AR Antagonists Major Manufacturers Table 4. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Prostate Cancer Major Manufacturers Table 6. Breast Cancer Major Manufacturers Table 7. Others Major Manufacturers Table 8. Androgen Receptor (AR) Antagonist Industry Trends Table 9. Androgen Receptor (AR) Antagonist Industry Drivers Table 10. Androgen Receptor (AR) Antagonist Industry Opportunities and Challenges Table 11. Androgen Receptor (AR) Antagonist Industry Restraints Table 12. Global Androgen Receptor (AR) Antagonist Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Androgen Receptor (AR) Antagonist Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Androgen Receptor (AR) Antagonist Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021-2026) Table 16. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2027-2032) Table 17. Global Androgen Receptor (AR) Antagonist Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Tons) Table 18. Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2026) & (K Tons) Table 19. Global Androgen Receptor (AR) Antagonist Sales by Region (2027-2032) & (K Tons) Table 20. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2021-2026) Table 21. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2027-2032) Table 22. Global Androgen Receptor (AR) Antagonist Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Androgen Receptor (AR) Antagonist Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers (2021-2026) Table 26. Global Androgen Receptor (AR) Antagonist Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 27. Global Androgen Receptor (AR) Antagonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Androgen Receptor (AR) Antagonist Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Androgen Receptor (AR) Antagonist Manufacturers, Product Type & Application Table 30. Global Androgen Receptor (AR) Antagonist Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Androgen Receptor (AR) Antagonist by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Androgen Receptor (AR) Antagonist Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021-2026) Table 37. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2027-2032) Table 38. Global Androgen Receptor (AR) Antagonist Sales by Type 2021 VS 2025 VS 2032 (K Tons) Table 39. Global Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 40. Global Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 41. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021-2026) Table 42. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2027-2032) Table 43. Global Androgen Receptor (AR) Antagonist Price by Type (2021-2026) & (US$/Ton) Table 44. Global Androgen Receptor (AR) Antagonist Price by Type (2027-2032) & (US$/Ton) Table 45. Global Androgen Receptor (AR) Antagonist Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021-2026) Table 49. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2027-2032) Table 50. Global Androgen Receptor (AR) Antagonist Sales by Application 2021 VS 2025 VS 2032 (K Tons) Table 51. Global Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 52. Global Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 53. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021-2026) Table 54. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2027-2032) Table 55. Global Androgen Receptor (AR) Antagonist Price by Application (2021-2026) & (US$/Ton) Table 56. Global Androgen Receptor (AR) Antagonist Price by Application (2027-2032) & (US$/Ton) Table 57. Kaituo Pharmaceutical Company Information Table 58. Kaituo Pharmaceutical Business Overview Table 59. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 60. Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio Table 61. Kaituo Pharmaceutical Recent Development Table 62. Pfizer Company Information Table 63. Pfizer Business Overview Table 64. Pfizer Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 65. Pfizer Androgen Receptor (AR) Antagonist Product Portfolio Table 66. Pfizer Recent Development Table 67. Hengrui Medicine Company Information Table 68. Hengrui Medicine Business Overview Table 69. Hengrui Medicine Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 70. Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio Table 71. Hengrui Medicine Recent Development Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Bayer Androgen Receptor (AR) Antagonist Product Portfolio Table 76. Bayer Recent Development Table 77. R&D Systems Company Information Table 78. R&D Systems Business Overview Table 79. R&D Systems Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio Table 81. R&D Systems Recent Development Table 82. Janssen Pharmaceuticals Company Information Table 83. Janssen Pharmaceuticals Business Overview Table 84. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio Table 86. Janssen Pharmaceuticals Recent Development Table 87. Astellas Pharma Company Information Table 88. Astellas Pharma Business Overview Table 89. Astellas Pharma Androgen Receptor (AR) Antagonist Sales (K Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio Table 91. Astellas Pharma Recent Development Table 92. North America Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 95. North America Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 96. North America Androgen Receptor (AR) Antagonist Sales Price by Type (2021-2026) & (US$/Ton) Table 97. North America Androgen Receptor (AR) Antagonist Sales Price by Type (2027-2032) & (US$/Ton) Table 98. North America Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 101. North America Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 102. North America Androgen Receptor (AR) Antagonist Sales Price by Application (2021-2026) & (US$/Ton) Table 103. North America Androgen Receptor (AR) Antagonist Sales Price by Application (2027-2032) & (US$/Ton) Table 104. North America Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 108. North America Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 109. North America Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 110. North America Androgen Receptor (AR) Antagonist Sales Price by Country (2021-2026) & (US$/Ton) Table 111. North America Androgen Receptor (AR) Antagonist Sales Price by Country (2027-2032) & (US$/Ton) Table 112. United States Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 113. Canada Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 114. Mexico Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 115. Europe Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 118. Europe Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 119. Europe Androgen Receptor (AR) Antagonist Sales Price by Type (2021-2026) & (US$/Ton) Table 120. Europe Androgen Receptor (AR) Antagonist Sales Price by Type (2027-2032) & (US$/Ton) Table 121. Europe Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 124. Europe Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 125. Europe Androgen Receptor (AR) Antagonist Sales Price by Application (2021-2026) & (US$/Ton) Table 126. Europe Androgen Receptor (AR) Antagonist Sales Price by Application (2027-2032) & (US$/Ton) Table 127. Europe Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 131. Europe Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 132. Europe Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 133. Europe Androgen Receptor (AR) Antagonist Sales Price by Country (2021-2026) & (US$/Ton) Table 134. Europe Androgen Receptor (AR) Antagonist Sales Price by Country (2027-2032) & (US$/Ton) Table 135. Germany Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 136. France Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 137. U.K. Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 138. Italy Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 139. Russia Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 140. Spain Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 142. Switzerland Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 143. Sweden Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 144. Poland Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 145. China Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 146. China Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 147. China Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 148. China Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 149. China Androgen Receptor (AR) Antagonist Sales Price by Type (2021-2026) & (US$/Ton) Table 150. China Androgen Receptor (AR) Antagonist Sales Price by Type (2027-2032) & (US$/Ton) Table 151. China Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 152. China Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 153. China Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 154. China Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 155. China Androgen Receptor (AR) Antagonist Sales Price by Application (2021-2026) & (US$/Ton) Table 156. China Androgen Receptor (AR) Antagonist Sales Price by Application (2027-2032) & (US$/Ton) Table 157. Asia Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 160. Asia Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 161. Asia Androgen Receptor (AR) Antagonist Sales Price by Type (2021-2026) & (US$/Ton) Table 162. Asia Androgen Receptor (AR) Antagonist Sales Price by Type (2027-2032) & (US$/Ton) Table 163. Asia Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 166. Asia Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 167. Asia Androgen Receptor (AR) Antagonist Sales Price by Application (2021-2026) & (US$/Ton) Table 168. Asia Androgen Receptor (AR) Antagonist Sales Price by Application (2027-2032) & (US$/Ton) Table 169. Asia Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 173. Asia Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 174. Asia Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 175. Asia Androgen Receptor (AR) Antagonist Sales Price by Country (2021-2026) & (US$/Ton) Table 176. Asia Androgen Receptor (AR) Antagonist Sales Price by Country (2027-2032) & (US$/Ton) Table 177. Japan Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 178. South Korea Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 179. India Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 180. Australia Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 181. Taiwan Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Androgen Receptor (AR) Antagonist Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Androgen Receptor (AR) Antagonist Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Androgen Receptor (AR) Antagonist Sales by Type (2021-2026) & (K Tons) Table 186. SAMEA Androgen Receptor (AR) Antagonist Sales by Type (2027-2032) & (K Tons) Table 187. SAMEA Androgen Receptor (AR) Antagonist Sales Price by Type (2021-2026) & (US$/Ton) Table 188. SAMEA Androgen Receptor (AR) Antagonist Sales Price by Type (2027-2032) & (US$/Ton) Table 189. SAMEA Androgen Receptor (AR) Antagonist Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Androgen Receptor (AR) Antagonist Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Androgen Receptor (AR) Antagonist Sales by Application (2021-2026) & (K Tons) Table 192. SAMEA Androgen Receptor (AR) Antagonist Sales by Application (2027-2032) & (K Tons) Table 193. SAMEA Androgen Receptor (AR) Antagonist Sales Price by Application (2021-2026) & (US$/Ton) Table 194. SAMEA Androgen Receptor (AR) Antagonist Sales Price by Application (2027-2032) & (US$/Ton) Table 195. SAMEA Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032) & (K Tons) Table 199. SAMEA Androgen Receptor (AR) Antagonist Sales by Country (2021-2026) & (K Tons) Table 200. SAMEA Androgen Receptor (AR) Antagonist Sales by Country (2027-2032) & (K Tons) Table 201. SAMEA Androgen Receptor (AR) Antagonist Sales Price by Country (2021-2026) & (US$/Ton) Table 202. SAMEA Androgen Receptor (AR) Antagonist Sales Price by Country (2027-2032) & (US$/Ton) Table 203. Brazil Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 204. Argentina Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 205. Chile Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 206. Colombia Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 207. Peru Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 209. Israel Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 210. UAE Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 211. Turkey Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 212. Iran Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 213. Egypt Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Androgen Receptor (AR) Antagonist Distributors List Table 217. Androgen Receptor (AR) Antagonist Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Androgen Receptor (AR) Antagonist Image Figure 2. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Androgen Receptor (AR) Antagonist Market Size Share 2021 VS 2025 VS 2032 Figure 4. Steroidal AR Antagonists Image Figure 5. Nonsteroidal AR Antagonists Image Figure 6. Global Androgen Receptor (AR) Antagonist Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Androgen Receptor (AR) Antagonist Market Size Share 2021 VS 2025 VS 2032 Figure 8. Prostate Cancer Image Figure 9. Breast Cancer Image Figure 10. Others Image Figure 11. Global Androgen Receptor (AR) Antagonist Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Androgen Receptor (AR) Antagonist Revenue (2021-2032) & (US$ Million) Figure 13. Global Androgen Receptor (AR) Antagonist Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021-2032) Figure 16. Global Androgen Receptor (AR) Antagonist Sales (2021-2032) & (K Tons) Figure 17. Global Androgen Receptor (AR) Antagonist Sales by Region: 2021 VS 2025 VS 2032 (K Tons) Figure 18. Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Androgen Receptor (AR) Antagonist Sales YoY (2021-2032) & (K Tons) Figure 20. Europe Androgen Receptor (AR) Antagonist Sales YoY (2021-2032) & (K Tons) Figure 21. China Androgen Receptor (AR) Antagonist Sales YoY (2021-2032) & (K Tons) Figure 22. Asia (Excluding China) Androgen Receptor (AR) Antagonist Sales YoY (2021-2032) & (K Tons) Figure 23. South America, Middle East and Africa Androgen Receptor (AR) Antagonist Sales YoY (2021-2032) & (K Tons) Figure 24. Global Androgen Receptor (AR) Antagonist Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Androgen Receptor (AR) Antagonist Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Androgen Receptor (AR) Antagonist Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021-2032) Figure 30. Global Androgen Receptor (AR) Antagonist Sales by Type (2021 VS 2025 VS 2032) & (K Tons) Figure 31. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021-2032) Figure 33. Global Androgen Receptor (AR) Antagonist Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021-2032) Figure 36. Global Androgen Receptor (AR) Antagonist Sales by Application (2021 VS 2025 VS 2032) & (K Tons) Figure 37. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021-2032) Figure 39. North America Androgen Receptor (AR) Antagonist Revenue Share by Type (2021-2032) Figure 40. North America Androgen Receptor (AR) Antagonist Sales Share by Type (2021-2032) Figure 41. North America Androgen Receptor (AR) Antagonist Revenue Share by Application (2021-2032) Figure 42. North America Androgen Receptor (AR) Antagonist Sales Share by Application (2021-2032) Figure 43. North America Androgen Receptor (AR) Antagonist Revenue Share by Country (2021-2032) Figure 44. North America Androgen Receptor (AR) Antagonist Sales Share by Country (2021-2032) Figure 45. Europe Androgen Receptor (AR) Antagonist Revenue Share by Type (2021-2032) Figure 46. Europe Androgen Receptor (AR) Antagonist Sales Share by Type (2021-2032) Figure 47. Europe Androgen Receptor (AR) Antagonist Revenue Share by Application (2021-2032) Figure 48. Europe Androgen Receptor (AR) Antagonist Sales Share by Application (2021-2032) Figure 49. Europe Androgen Receptor (AR) Antagonist Revenue Share by Country (2021-2032) Figure 50. Europe Androgen Receptor (AR) Antagonist Sales Share by Country (2021-2032) Figure 51. China Androgen Receptor (AR) Antagonist Revenue Share by Type (2021-2032) Figure 52. China Androgen Receptor (AR) Antagonist Sales Share by Type (2021-2032) Figure 53. China Androgen Receptor (AR) Antagonist Revenue Share by Application (2021-2032) Figure 54. China Androgen Receptor (AR) Antagonist Sales Share by Application (2021-2032) Figure 55. Asia Androgen Receptor (AR) Antagonist Revenue Share by Type (2021-2032) Figure 56. Asia Androgen Receptor (AR) Antagonist Sales Share by Type (2021-2032) Figure 57. Asia Androgen Receptor (AR) Antagonist Revenue Share by Application (2021-2032) Figure 58. Asia Androgen Receptor (AR) Antagonist Sales Share by Application (2021-2032) Figure 59. Asia Androgen Receptor (AR) Antagonist Revenue Share by Country (2021-2032) Figure 60. Asia Androgen Receptor (AR) Antagonist Sales Share by Country (2021-2032) Figure 61. SAMEA Androgen Receptor (AR) Antagonist Revenue Share by Type (2021-2032) Figure 62. SAMEA Androgen Receptor (AR) Antagonist Sales Share by Type (2021-2032) Figure 63. SAMEA Androgen Receptor (AR) Antagonist Revenue Share by Application (2021-2032) Figure 64. SAMEA Androgen Receptor (AR) Antagonist Sales Share by Application (2021-2032) Figure 65. SAMEA Androgen Receptor (AR) Antagonist Revenue Share by Country (2021-2032) Figure 66. SAMEA Androgen Receptor (AR) Antagonist Sales Share by Country (2021-2032) Figure 67. Androgen Receptor (AR) Antagonist Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Androgen Receptor (AR) Antagonist Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Steroidal AR Antagonists
  • Nonsteroidal AR Antagonists
Applications
  • Prostate Cancer
  • Breast Cancer
  • Others
Companies covered
  • Kaituo Pharmaceutical
  • Pfizer
  • Hengrui Medicine
  • Bayer
  • R&D Systems
  • Janssen Pharmaceuticals
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Androgen Receptor (AR) Antagonist Market by Type
  3. 1.2.1 Global Androgen Receptor (AR) Antagonist Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Steroidal AR Antagonists
  5. 1.2.3 Nonsteroidal AR Antagonists
  6. 1.3 Androgen Receptor (AR) Antagonist Market by Application
  7. 1.3.1 Global Androgen Receptor (AR) Antagonist Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Prostate Cancer
  9. 1.3.3 Breast Cancer
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Androgen Receptor (AR) Antagonist Market Dynamics
  1. 2.1 Androgen Receptor (AR) Antagonist Industry Trends
  2. 2.2 Androgen Receptor (AR) Antagonist Industry Drivers
  3. 2.3 Androgen Receptor (AR) Antagonist Industry Opportunities and Challenges
  4. 2.4 Androgen Receptor (AR) Antagonist Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Androgen Receptor (AR) Antagonist Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Androgen Receptor (AR) Antagonist Revenue by Region
  3. 3.2.1 Global Androgen Receptor (AR) Antagonist Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Androgen Receptor (AR) Antagonist Revenue by Region (2021-2026)
  5. 3.2.3 Global Androgen Receptor (AR) Antagonist Revenue by Region (2027-2032)
  6. 3.2.4 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Androgen Receptor (AR) Antagonist Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Androgen Receptor (AR) Antagonist Sales by Region
  9. 3.4.1 Global Androgen Receptor (AR) Antagonist Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Androgen Receptor (AR) Antagonist Sales by Region (2021-2026)
  11. 3.4.3 Global Androgen Receptor (AR) Antagonist Sales by Region (2027-2032)
  12. 3.4.4 Global Androgen Receptor (AR) Antagonist Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Androgen Receptor (AR) Antagonist Revenue by Manufacturers
  2. 4.1.1 Global Androgen Receptor (AR) Antagonist Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Androgen Receptor (AR) Antagonist Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Androgen Receptor (AR) Antagonist Sales by Manufacturers
  6. 4.2.1 Global Androgen Receptor (AR) Antagonist Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Androgen Receptor (AR) Antagonist Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Androgen Receptor (AR) Antagonist Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Androgen Receptor (AR) Antagonist Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Androgen Receptor (AR) Antagonist Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Androgen Receptor (AR) Antagonist Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Androgen Receptor (AR) Antagonist Manufacturers, Product Type & Application
  13. 4.7 Global Androgen Receptor (AR) Antagonist Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Androgen Receptor (AR) Antagonist Market CR5 and HHI
  16. 4.8.2 2025 Androgen Receptor (AR) Antagonist Tier 1, Tier 2, and Tier 3
5 Androgen Receptor (AR) Antagonist Market by Type
  1. 5.1 Global Androgen Receptor (AR) Antagonist Revenue by Type
  2. 5.1.1 Global Androgen Receptor (AR) Antagonist Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Androgen Receptor (AR) Antagonist Sales by Type
  6. 5.2.1 Global Androgen Receptor (AR) Antagonist Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Androgen Receptor (AR) Antagonist Sales by Type (2021-2032) & (K Tons)
  8. 5.2.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Type (2021-2032)
  9. 5.3 Global Androgen Receptor (AR) Antagonist Price by Type
6 Androgen Receptor (AR) Antagonist Market by Application
  1. 6.1 Global Androgen Receptor (AR) Antagonist Revenue by Application
  2. 6.1.1 Global Androgen Receptor (AR) Antagonist Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Androgen Receptor (AR) Antagonist Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Androgen Receptor (AR) Antagonist Sales by Application
  6. 6.2.1 Global Androgen Receptor (AR) Antagonist Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Androgen Receptor (AR) Antagonist Sales by Application (2021-2032) & (K Tons)
  8. 6.2.3 Global Androgen Receptor (AR) Antagonist Sales Market Share by Application (2021-2032)
  9. 6.3 Global Androgen Receptor (AR) Antagonist Price by Application
7 Company Profiles
  1. 7.1 Kaituo Pharmaceutical
  2. 7.1.1 Kaituo Pharmaceutical Company Information
  3. 7.1.2 Kaituo Pharmaceutical Business Overview
  4. 7.1.3 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Kaituo Pharmaceutical Androgen Receptor (AR) Antagonist Product Portfolio
  6. 7.1.5 Kaituo Pharmaceutical Recent Developments
  7. 7.2 Pfizer
  8. 7.2.1 Pfizer Company Information
  9. 7.2.2 Pfizer Business Overview
  10. 7.2.3 Pfizer Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Pfizer Androgen Receptor (AR) Antagonist Product Portfolio
  12. 7.2.5 Pfizer Recent Developments
  13. 7.3 Hengrui Medicine
  14. 7.3.1 Hengrui Medicine Company Information
  15. 7.3.2 Hengrui Medicine Business Overview
  16. 7.3.3 Hengrui Medicine Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hengrui Medicine Androgen Receptor (AR) Antagonist Product Portfolio
  18. 7.3.5 Hengrui Medicine Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Androgen Receptor (AR) Antagonist Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 R&D Systems
  26. 7.5.1 R&D Systems Company Information
  27. 7.5.2 R&D Systems Business Overview
  28. 7.5.3 R&D Systems Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 R&D Systems Androgen Receptor (AR) Antagonist Product Portfolio
  30. 7.5.5 R&D Systems Recent Developments
  31. 7.6 Janssen Pharmaceuticals
  32. 7.6.1 Janssen Pharmaceuticals Company Information
  33. 7.6.2 Janssen Pharmaceuticals Business Overview
  34. 7.6.3 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Janssen Pharmaceuticals Androgen Receptor (AR) Antagonist Product Portfolio
  36. 7.6.5 Janssen Pharmaceuticals Recent Developments
  37. 7.7 Astellas Pharma
  38. 7.7.1 Astellas Pharma Company Information
  39. 7.7.2 Astellas Pharma Business Overview
  40. 7.7.3 Astellas Pharma Androgen Receptor (AR) Antagonist Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Astellas Pharma Androgen Receptor (AR) Antagonist Product Portfolio
  42. 7.7.5 Astellas Pharma Recent Developments
8 North America
  1. 8.1 North America Androgen Receptor (AR) Antagonist Market Size by Type
  2. 8.1.1 North America Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032)
  3. 8.1.2 North America Androgen Receptor (AR) Antagonist Sales by Type (2021-2032)
  4. 8.1.3 North America Androgen Receptor (AR) Antagonist Price by Type (2021-2032)
  5. 8.2 North America Androgen Receptor (AR) Antagonist Market Size by Application
  6. 8.2.1 North America Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032)
  7. 8.2.2 North America Androgen Receptor (AR) Antagonist Sales by Application (2021-2032)
  8. 8.2.3 North America Androgen Receptor (AR) Antagonist Price by Application (2021-2032)
  9. 8.3 North America Androgen Receptor (AR) Antagonist Market Size by Country
  10. 8.3.1 North America Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Androgen Receptor (AR) Antagonist Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Androgen Receptor (AR) Antagonist Market Size by Type
  2. 9.1.1 Europe Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032)
  3. 9.1.2 Europe Androgen Receptor (AR) Antagonist Sales by Type (2021-2032)
  4. 9.1.3 Europe Androgen Receptor (AR) Antagonist Price by Type (2021-2032)
  5. 9.2 Europe Androgen Receptor (AR) Antagonist Market Size by Application
  6. 9.2.1 Europe Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032)
  7. 9.2.2 Europe Androgen Receptor (AR) Antagonist Sales by Application (2021-2032)
  8. 9.2.3 Europe Androgen Receptor (AR) Antagonist Price by Application (2021-2032)
  9. 9.3 Europe Androgen Receptor (AR) Antagonist Market Size by Country
  10. 9.3.1 Europe Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Androgen Receptor (AR) Antagonist Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Androgen Receptor (AR) Antagonist Market Size by Type
  2. 10.1.1 China Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032)
  3. 10.1.2 China Androgen Receptor (AR) Antagonist Sales by Type (2021-2032)
  4. 10.1.3 China Androgen Receptor (AR) Antagonist Price by Type (2021-2032)
  5. 10.2 China Androgen Receptor (AR) Antagonist Market Size by Application
  6. 10.2.1 China Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032)
  7. 10.2.2 China Androgen Receptor (AR) Antagonist Sales by Application (2021-2032)
  8. 10.2.3 China Androgen Receptor (AR) Antagonist Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Androgen Receptor (AR) Antagonist Market Size by Type
  2. 11.1.1 Asia Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032)
  3. 11.1.2 Asia Androgen Receptor (AR) Antagonist Sales by Type (2021-2032)
  4. 11.1.3 Asia Androgen Receptor (AR) Antagonist Price by Type (2021-2032)
  5. 11.2 Asia Androgen Receptor (AR) Antagonist Market Size by Application
  6. 11.2.1 Asia Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032)
  7. 11.2.2 Asia Androgen Receptor (AR) Antagonist Sales by Application (2021-2032)
  8. 11.2.3 Asia Androgen Receptor (AR) Antagonist Price by Application (2021-2032)
  9. 11.3 Asia Androgen Receptor (AR) Antagonist Market Size by Country
  10. 11.3.1 Asia Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Androgen Receptor (AR) Antagonist Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Androgen Receptor (AR) Antagonist Market Size by Type
  2. 12.1.1 SAMEA Androgen Receptor (AR) Antagonist Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Androgen Receptor (AR) Antagonist Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Androgen Receptor (AR) Antagonist Price by Type (2021-2032)
  5. 12.2 SAMEA Androgen Receptor (AR) Antagonist Market Size by Application
  6. 12.2.1 SAMEA Androgen Receptor (AR) Antagonist Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Androgen Receptor (AR) Antagonist Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Androgen Receptor (AR) Antagonist Price by Application (2021-2032)
  9. 12.3 SAMEA Androgen Receptor (AR) Antagonist Market Size by Country
  10. 12.3.1 SAMEA Androgen Receptor (AR) Antagonist Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Androgen Receptor (AR) Antagonist Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Androgen Receptor (AR) Antagonist Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Androgen Receptor (AR) Antagonist Value Chain Analysis
  2. 13.1.1 Androgen Receptor (AR) Antagonist Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Androgen Receptor (AR) Antagonist Production Mode & Process
  6. 13.2 Androgen Receptor (AR) Antagonist Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Androgen Receptor (AR) Antagonist Distributors
  9. 13.2.3 Androgen Receptor (AR) Antagonist Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst